Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSD17B3 | P37058 | 1/20 | 0.64 |
| ▸ | CA2 | P00918 | 2/20 | 0.50 |
| ▸ | CA12 | O43570 | 2/20 | 0.50 |
| ▸ | CA1 | P00915 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | GLA | P06280 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | CASP1 | P29466 | 1/20 | 0.50 |
| ▸ | CASP7 | P55210 | 1/20 | 0.50 |
| ▸ | CA9 | Q16790 | 1/20 | 0.50 |
| ▸ | MAOB | P27338 | 3/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | CA5A | P35218 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29384323 | 1.00 | HSD17B3 (0.64) | HSD17B3CA2CA12CA1ALDH1A1 | |
| Acetic Acid SCHEMBL25422567 | 0.92 | HSD17B3 (0.59) | HSD17B3CA2CA12CA1ALDH1A1 | |
| SCHEMBL16284310 | 0.85 | NPC1 (0.57) | HSD17B3CA2CA12CA1ALDH1A1 | |
| SCHEMBL890223 | 0.81 | HSD17B3 (0.68) | HSD17B3CA2CA12CA1ALDH1A1 | |
| SCHEMBL16085333 | 0.81 | SMN1; SMN2 (0.63) | HSD17B3CA2CA12CA1ALDH1A1 | |
| SCHEMBL31631412 | 0.79 | MAOA (0.48) | HSD17B3CA2CA12CA1ALDH1A1 | |
| SCHEMBL18517563 | 0.78 | CA2 (0.50) | HSD17B3CA2CA12CA1ALDH1A1 | |
| SCHEMBL126040 | 0.78 | HSD17B3 (1.00) | HSD17B3CA12CA1ALDH1A1HPGD | |
| SCHEMBL31415663 | 0.78 | HSD17B3 (0.64) | HSD17B3CA2CA12CA1ALDH1A1 | |
| SCHEMBL31631414 | 0.77 | CA2 (0.46) | HSD17B3CA2CA12CA1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 564 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006041523-A1 | FLUORESCENT POLY(ALKYLENE TEREPHTHALATE) COMPOSITIONS | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2006-04-20 | — | — | WO | claimed |
| EP-0347771-A2 | Device for enhancing fluorescence and kinetics and methods of using the device | Becton, Dickinson and Company (US) | 1989-12-27 | — | — | EP | claimed |
| US-4798788-A | Processes and materials for carrying out microchemical and microbiological tests | DADE BEHRING INC. | 1989-01-17 | — | — | US | claimed |
| JP-2046280-A | — | — | None | — | — | JP | disclosed |
| US-20260140105-A1 | METHODS AND SYSTEMS FOR ANALYTE DETECTION AND ANALYSIS | ULTIMA GENOMICS INC (US) | 2026-05-21 | — | — | US | disclosed |
| US-20260116065-A1 | SYSTEMS AND METHODS FOR SPATIAL SCREENING OF ANALYTES | ULTIMA GENOMICS INC (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260103741-A1 | NUCLEIC ACID CLONAL AMPLIFICATION AND SEQUENCING METHODS, SYSTEMS, AND KITS | ULTIMA GENOMICS INC (US) | 2026-04-16 | — | — | US | disclosed |
| US-20260078438-A1 | METHODS FOR NUCLEIC ACID ANALYSIS | ULTIMA GENOMICS INC (US) | 2026-03-19 | — | — | US | disclosed |
| US-20260069175-A1 | SAMPLE-TO-ANSWER DIAGNOSTIC SYSTEM FOR THE DETECTION OF CIRCULATING HISTONES IN WHOLE BLOOD | UNIV MARYLAND (US) | 2026-03-12 | — | — | US | disclosed |
| US-12571036-B2 | Methods, devices, and systems for analyte detection and analysis | ULTIMA GENOMICS, INC. (US) | 2026-03-10 | — | — | US | disclosed |
| US-12559790-B2 | Compositions and methods for analyte detection | 10X GENOMICS, INC. (US) | 2026-02-24 | — | — | US | disclosed |
| EP-0452330-A1 | METHOD AND APPARATUS FOR DIAGNOSING INTRACELLULAR PARASITE INFECTIONS USING AN ENZYME DETECTION SYSTEM | TOTEM HEALTH SCIENCES, INC. (CA) | 1991-10-23 | — | — | EP | disclosed |
| WO-1990004644-A1 | METHOD AND APPARATUS FOR DIAGNOSING INTRACELLULAR PARASITE INFECTIONS USING AN ENZYME DETECTION SYSTEM | TOTEM HEALTH SCIENCES, INC. (CA) | 1990-05-03 | — | — | WO | disclosed |
| JP-H0246280-A | DEVICE FOR ENHANCING FLUORESCENCE AND REACTION RATE AND ITS USE | BECTON DICKINSON & CO | 1990-02-15 | — | — | JP | disclosed |
| EP-0039719-B1 | MOTION PICTURE FILM HAVING DIGITALLY CODED SOUNDTRACK AND METHOD FOR PRODUCTION THEREOF | CUSTER, Peter Anderson (US) | 1985-10-16 | — | — | EP | disclosed |
| US-4366217-A | Motion picture film having digitally coded soundtrack and method for production thereof | BIRD GEORGE | 1982-12-28 | — | — | US | disclosed |
| EP-0039719-A4 | MOTION PICTURE FILM HAVING DIGITALLY CODED SOUNDTRACK AND METHOD FOR PRODUCTION THEREOF. | CUSTER PETER ANDERSON (US) | 1982-03-03 | — | — | EP | disclosed |
| US-4308327-A | Motion picture film having digitally coded soundtrack and method for production thereof | BIRD GEORGE | 1981-12-29 | — | — | US | disclosed |
| EP-0039719-A1 | MOTION PICTURE FILM HAVING DIGITALLY CODED SOUNDTRACK AND METHOD FOR PRODUCTION THEREOF. | CUSTER PETER ANDERSON (US) | 1981-11-18 | — | — | EP | disclosed |
| WO-1981001204-A1 | MOTION PICTURE FILM HAVING DIGITALLY CODED SOUNDTRACK AND METHOD FOR PRODUCTION THEREOF | CUSTER P | 1981-04-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559790-B2 | Compositions and methods for analyte detection | DNMT3A, F13B, F13A1 | HSD17B3 3309/4885CA2 4183/4885CA12 1654/4885 |
| US-20260069175-A1 | SAMPLE-TO-ANSWER DIAGNOSTIC SYSTEM FOR THE DETECTION OF CIRCULATING HISTONES IN WHOLE BLOOD | H1-3, H1-2, H1-4 | HSD17B3 4240/4885CA2 1703/4885CA12 469/4885 |
| US-20260140105-A1 | METHODS AND SYSTEMS FOR ANALYTE DETECTION AND ANALYSIS | SRMS, CFD, STUB1 | HSD17B3 2099/4885CA2 1756/4885CA12 46/4885 |
| US-20260103741-A1 | NUCLEIC ACID CLONAL AMPLIFICATION AND SEQUENCING METHODS, SYSTEMS, AND KITS | DNMT3A, POLB, POLL | HSD17B3 4337/4885CA2 2637/4885CA12 2503/4885 |
| US-12571036-B2 | Methods, devices, and systems for analyte detection and analysis | ADAR, POLI, DNA2 | HSD17B3 4498/4885CA2 207/4885CA12 368/4885 |
| US-20260116065-A1 | SYSTEMS AND METHODS FOR SPATIAL SCREENING OF ANALYTES | APP, KLK3, HAVCR2 | HSD17B3 2652/4885CA2 484/4885CA12 67/4885 |
| US-20260078438-A1 | METHODS FOR NUCLEIC ACID ANALYSIS | POLL, POLM, POLRMT | HSD17B3 2929/4885CA2 4816/4885CA12 4175/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.